South Korea plus the US keep on being the business's Principal markets, but 3billion is seeking to concentrate on "anyone who wants our providers at this stage," Keum said. The company, founded in Oct 2016 as a spinoff from Korean genomic products and services provider Macrogen, has by now lifted funds from the non-public fairness industry this